Three inaugural honorary members appointed by NPS; Kay Price reappointed to NPS Board

18 November 2011

Three honorary members of NPS have been appointed by the NPS Board following an extensive call for nominations and shortlisting process.

The NPS Board resolved unanimously to invite consumer health advocate Ms Jan Donovan, leading figure in Australian health Professor Emeritus Lloyd Sansom AO and long-standing quality use of medicines advocate Professor Richard Day AM to become honorary members of NPS.

NPS Chair Dr Janette Randall says each of the inaugural honorary members have demonstrated a strong and ongoing contribution to quality use of medicines over the years.

“The NPS constitution was revised in 2010 to enable the Board to publicly recognise individuals who have made outstanding contributions towards quality use of medicines,” says Dr Randall.

“On behalf of the Board I would like to thank Ms Donovan, Professor Sansom and Professor Day for their support of NPS and its work over the years, and congratulate them on their appointment as honorary members.”

Kay Price rappointed to NPS Board

The NPS Board has also endorsed the appointment of Associate Professor Kay Price as the Health Practitioner Class (Other) Director for a further term of three years.

Dr Randall says the Board looks forward to continuing to work with A/Prof Price, especially given her extensive knowledge of policy directions and emerging trends relevant to nursing and quality use of medicines and medical tests.

“We are delighted that we will continue to benefit from Kay’s extensive, established networks, and her broad and in-depth understanding of nursing in Australia,” says Dr Randall.

Associate Professor at the School of Nursing & Midwifery, University of South Australia and an experienced and active qualitative researcher, Kay was appointed to the NPS Board in 2008. She is a member of the NPS Board Governance and Nomination Committee and represents the Board on the Program Evaluation and Research Development Advisory Group.


Independent, evidence-based and not-for-profit, NPS enables better decisions about medicines and medical tests.We are funded by the Australian Government Department of Health and Ageing.